Immune Design (IMDZ) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access IMDZ Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Immune Design finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2018)
(Sep 30 2018) (Jun 30 2018) (Mar 31 2018) (Dec 31 2017)
Assets
Cash & cash equivalent77.94
Restricted Cash and Cash Equivalents, Current0.00
Available-for-sale Securities, Current MA17.95
Cash & Short-term Investments94.00
Accounts receivable0.71
Other Receivables, Net, Current0.00
Inventories0.09
Other Current Assets1.79
Prepaid Expense, Current AS1.76
Total Current Assets100.23
Equipment/Property/Plant Net0.54
Deposits Assets, Noncurrent AS0.20
Other Assets, Noncurrent0.00
Total Assets100.96
Liabilities
Accounts Payable, Current AC1.48
Accrued Liabilities, Current AC7.37
Estimated Litigation Liability, Current0.00
Total Current Liabilities8.85
Total Long-term Debt0.00
Other liabilities, Noncurrent0.11
Total Liabilities8.96
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock382.47
Retained Earnings / Accumulated Deficit-290.52
Other Equity0.00
Common Stockholder's Equity92.01
Total Stockholder's Equity92.01
Liabilities & Stockholder's Equity100.96
4 historic quarters locked

Sign in to unlock the full Immune Design balance sheet history.

About IMDZ Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.